comparemela.com

Latest Breaking News On - Joe catanzaro - Page 1 : comparemela.com

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q1 2024 Earnings Call Transcript

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

Philadelphia
Pennsylvania
United-states
Australia
Greece
Canada
United-kingdom
American
Greek
Reni-benjamin
Peter-lawson
Jean-marc-bellemin

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q1 2024 Earnings Call Transcript

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

Greece
United-states
Japan
America
Japanese
Greek
Steven-miller
Dydo-pharma
Michael-kalb
Mike-kalb
Jason-gerberry
Joon-lee

Aadi Bioscience, Inc. (NASDAQ:AADI) Q1 2024 Earnings Call Transcript

Aadi Bioscience, Inc. (NASDAQ:AADI) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

Scott-giacobello
Joe-catanzaro
Piper-sandler
Audrey-gross
Dave-lennon
Aadi-bioscience
Loretta-itri
Joseph-catanzaro
Aadi-bioscience-inc
Exchange-commission
Nasdaq

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q1 2024 Earnings Call Transcript

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

Roche-biontech
Chris-ogden
Piper-sandler
Sean-mccarthy
Amgen-tarlatamab
Joe-catanzaro
Peter-lawson
Wayne-chu
Zhen-su
Cytomx-therapeutics-inc
Nasdaq
Bristol-myers-squibb

Exelixis, Inc. (NASDAQ:EXEL) Q1 2024 Earnings Call Transcript

Exelixis, Inc. (NASDAQ:EXEL) Q1 2024 Earnings Call Transcript April 30, 2024 Exelixis, Inc. misses on earnings expectations. Reported EPS is $0.17 EPS, expectations were $0.28. EXEL isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, ladies and gentlemen, and […]

Michael-morrissey
Peter-lamb
Jennifer-chan
Cabo-atezo
Monty-pal
Laura-dillard
Neeraj-agarwal
Joe-catanzaro
Dana-aftab
Broad-institute
Alliance-for-clinical-trials-in-oncology

vimarsana © 2020. All Rights Reserved.